Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts: implications for adjuvant treatment
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 16, 2022
|
| In: |
Journal of clinical oncology
Year: 2022, Jahrgang: 40, Heft: 32, Pages: 3741-3749 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.22.00202 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.22.00202 Resolving-System: http://dx.doi.org/10.1200/JCO.22.00202 Verlag, lizenzpflichtig, Volltext: http://ascopubs.org/doi/pdf/10.1200/JCO.22.00202?role=tab |
| Verfasserangaben: | Claus Garbe, Ulrike Keim, Teresa Amaral, Carola Berking, Thomas K. Eigentler, Lukas Flatz, Anja Gesierich, Ulrike Leiter, Rudolf Stadler, Cord Sunderkötter, Thomas Tüting, Jochen Utikal, Uwe Wollina, Lisa Zimmer, Christos C. Zouboulis, Paolo A. Ascierto, Alexander M. M. Eggermont, Jean-Jacques Grob, Axel Hauschild, Lidija Kandolf Sekulovic, Georgina V. Long, Jason J. Luke, Olivier Michielin, Ketty Peris, Dirk Schadendorf, John M. Kirkwood, and Paul C. Lorigan, on behalf of the Central Malignant Melanoma Registry (CMMR) |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1827515015 | ||
| 003 | DE-627 | ||
| 005 | 20240307090814.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221215s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.22.00202 |2 doi | |
| 035 | |a (DE-627)1827515015 | ||
| 035 | |a (DE-599)KXP1827515015 | ||
| 035 | |a (OCoLC)1425217451 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Garbe, Claus |d 1951- |e VerfasserIn |0 (DE-588)108397041 |0 (DE-627)516177893 |0 (DE-576)171143817 |4 aut | |
| 245 | 1 | 0 | |a Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts |b implications for adjuvant treatment |c Claus Garbe, Ulrike Keim, Teresa Amaral, Carola Berking, Thomas K. Eigentler, Lukas Flatz, Anja Gesierich, Ulrike Leiter, Rudolf Stadler, Cord Sunderkötter, Thomas Tüting, Jochen Utikal, Uwe Wollina, Lisa Zimmer, Christos C. Zouboulis, Paolo A. Ascierto, Alexander M. M. Eggermont, Jean-Jacques Grob, Axel Hauschild, Lidija Kandolf Sekulovic, Georgina V. Long, Jason J. Luke, Olivier Michielin, Ketty Peris, Dirk Schadendorf, John M. Kirkwood, and Paul C. Lorigan, on behalf of the Central Malignant Melanoma Registry (CMMR) |
| 264 | 1 | |c June 16, 2022 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Keim, Ulrike |e VerfasserIn |0 (DE-588)1214311237 |0 (DE-627)1725269317 |4 aut | |
| 700 | 1 | |a Amaral, Teresa |e VerfasserIn |0 (DE-588)1219099643 |0 (DE-627)1734832150 |4 aut | |
| 700 | 1 | |a Berking, Carola |d 1971- |e VerfasserIn |0 (DE-588)115659714 |0 (DE-627)077390121 |0 (DE-576)290004942 |4 aut | |
| 700 | 1 | |a Eigentler, Thomas |d 1973- |e VerfasserIn |0 (DE-588)128389710 |0 (DE-627)372633439 |0 (DE-576)187039062 |4 aut | |
| 700 | 1 | |a Flatz, Lukas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gesierich, Anja Heike |d 1975- |e VerfasserIn |0 (DE-588)124770665 |0 (DE-627)365934577 |0 (DE-576)29449300X |4 aut | |
| 700 | 1 | |a Leiter-Stöppke, Ulrike |e VerfasserIn |0 (DE-588)12025266X |0 (DE-627)696503913 |0 (DE-576)338721908 |4 aut | |
| 700 | 1 | |a Stadler, Rudolf |e VerfasserIn |0 (DE-588)1155182782 |0 (DE-627)1016515197 |0 (DE-576)501454640 |4 aut | |
| 700 | 1 | |a Sunderkötter, Cord |e VerfasserIn |0 (DE-588)1119936004 |0 (DE-627)873055284 |0 (DE-576)480081107 |4 aut | |
| 700 | 1 | |a Tüting, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 700 | 1 | |a Wollina, Uwe |d 1956- |e VerfasserIn |0 (DE-588)1128412179 |0 (DE-627)882897012 |0 (DE-576)485900432 |4 aut | |
| 700 | 1 | |a Zimmer, Lisa |d 1977- |e VerfasserIn |0 (DE-588)131597914 |0 (DE-627)511279620 |0 (DE-576)298613875 |4 aut | |
| 700 | 1 | |a Zouboulis, Christos C. |e VerfasserIn |0 (DE-588)105579980X |0 (DE-627)792713605 |0 (DE-576)411189689 |4 aut | |
| 700 | 1 | |a Ascierto, Paolo |e VerfasserIn |0 (DE-588)1195239076 |0 (DE-627)1677399627 |4 aut | |
| 700 | 1 | |a Eggermont, Alexander |e VerfasserIn |0 (DE-588)173227821 |0 (DE-627)698147405 |0 (DE-576)134077482 |4 aut | |
| 700 | 1 | |a Grob, Jean-Jacques |e VerfasserIn |0 (DE-588)1186178833 |0 (DE-627)166570036X |4 aut | |
| 700 | 1 | |a Hauschild, Axel |e VerfasserIn |0 (DE-588)120701200 |0 (DE-627)080838448 |0 (DE-576)292346670 |4 aut | |
| 700 | 1 | |a Sekulovic, Lidija Kandolf |e VerfasserIn |4 aut | |
| 700 | 1 | |a Long, Georgina |e VerfasserIn |0 (DE-588)1143993705 |0 (DE-627)100383440X |0 (DE-576)495243779 |4 aut | |
| 700 | 1 | |a Luke, Jason |e VerfasserIn |0 (DE-588)1271184974 |0 (DE-627)1819928195 |4 aut | |
| 700 | 1 | |a Michielin, Olivier |e VerfasserIn |0 (DE-588)1078044953 |0 (DE-627)837982138 |0 (DE-576)448933195 |4 aut | |
| 700 | 1 | |a Peris, Ketty |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Kirkwood, John M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lorigan, Paul C. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 40(2022), 32 vom: Nov., Seite 3741-3749 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts implications for adjuvant treatment |
| 773 | 1 | 8 | |g volume:40 |g year:2022 |g number:32 |g month:11 |g pages:3741-3749 |g extent:13 |a Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts implications for adjuvant treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1200/JCO.22.00202 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.22.00202 |x Resolving-System |
| 856 | 4 | 0 | |u http://ascopubs.org/doi/pdf/10.1200/JCO.22.00202?role=tab |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230711 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 25 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 12 | ||
| 999 | |a KXP-PPN1827515015 |e 4352028479 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Garbe","roleDisplay":"VerfasserIn","role":"aut","display":"Garbe, Claus","given":"Claus"},{"display":"Keim, Ulrike","role":"aut","given":"Ulrike","family":"Keim","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Amaral","display":"Amaral, Teresa","role":"aut","given":"Teresa"},{"family":"Berking","roleDisplay":"VerfasserIn","role":"aut","display":"Berking, Carola","given":"Carola"},{"family":"Eigentler","roleDisplay":"VerfasserIn","role":"aut","display":"Eigentler, Thomas","given":"Thomas"},{"display":"Flatz, Lukas","role":"aut","given":"Lukas","family":"Flatz","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Gesierich","role":"aut","display":"Gesierich, Anja Heike","given":"Anja Heike"},{"roleDisplay":"VerfasserIn","family":"Leiter-Stöppke","role":"aut","display":"Leiter-Stöppke, Ulrike","given":"Ulrike"},{"given":"Rudolf","role":"aut","display":"Stadler, Rudolf","family":"Stadler","roleDisplay":"VerfasserIn"},{"given":"Cord","role":"aut","display":"Sunderkötter, Cord","roleDisplay":"VerfasserIn","family":"Sunderkötter"},{"roleDisplay":"VerfasserIn","family":"Tüting","role":"aut","display":"Tüting, Thomas","given":"Thomas"},{"given":"Jochen","role":"aut","display":"Utikal, Jochen","family":"Utikal","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Wollina, Uwe","given":"Uwe","roleDisplay":"VerfasserIn","family":"Wollina"},{"display":"Zimmer, Lisa","role":"aut","given":"Lisa","family":"Zimmer","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Zouboulis","given":"Christos C.","display":"Zouboulis, Christos C.","role":"aut"},{"given":"Paolo","display":"Ascierto, Paolo","role":"aut","family":"Ascierto","roleDisplay":"VerfasserIn"},{"given":"Alexander","role":"aut","display":"Eggermont, Alexander","roleDisplay":"VerfasserIn","family":"Eggermont"},{"given":"Jean-Jacques","display":"Grob, Jean-Jacques","role":"aut","roleDisplay":"VerfasserIn","family":"Grob"},{"given":"Axel","display":"Hauschild, Axel","role":"aut","roleDisplay":"VerfasserIn","family":"Hauschild"},{"display":"Sekulovic, Lidija Kandolf","role":"aut","given":"Lidija Kandolf","roleDisplay":"VerfasserIn","family":"Sekulovic"},{"family":"Long","roleDisplay":"VerfasserIn","given":"Georgina","role":"aut","display":"Long, Georgina"},{"role":"aut","display":"Luke, Jason","given":"Jason","family":"Luke","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Michielin","given":"Olivier","role":"aut","display":"Michielin, Olivier"},{"given":"Ketty","display":"Peris, Ketty","role":"aut","roleDisplay":"VerfasserIn","family":"Peris"},{"role":"aut","display":"Schadendorf, Dirk","given":"Dirk","roleDisplay":"VerfasserIn","family":"Schadendorf"},{"role":"aut","display":"Kirkwood, John M.","given":"John M.","family":"Kirkwood","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Lorigan, Paul C.","given":"Paul C.","roleDisplay":"VerfasserIn","family":"Lorigan"}],"name":{"displayForm":["Claus Garbe, Ulrike Keim, Teresa Amaral, Carola Berking, Thomas K. Eigentler, Lukas Flatz, Anja Gesierich, Ulrike Leiter, Rudolf Stadler, Cord Sunderkötter, Thomas Tüting, Jochen Utikal, Uwe Wollina, Lisa Zimmer, Christos C. Zouboulis, Paolo A. Ascierto, Alexander M. M. Eggermont, Jean-Jacques Grob, Axel Hauschild, Lidija Kandolf Sekulovic, Georgina V. Long, Jason J. Luke, Olivier Michielin, Ketty Peris, Dirk Schadendorf, John M. Kirkwood, and Paul C. Lorigan, on behalf of the Central Malignant Melanoma Registry (CMMR)"]},"physDesc":[{"extent":"13 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2022","extent":"13","pages":"3741-3749","text":"40(2022), 32 vom: Nov., Seite 3741-3749","issue":"32","volume":"40"},"id":{"zdb":["2005181-5"],"eki":["313116962"],"issn":["1527-7755"]},"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}],"disp":"Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts implications for adjuvant treatmentJournal of clinical oncology","note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"recId":"313116962","pubHistory":["1.1983 -"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society of Clinical Oncology"}]}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"June 16, 2022"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1827515015","title":[{"title_sort":"Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts","title":"Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts","subtitle":"implications for adjuvant treatment"}],"id":{"eki":["1827515015"],"doi":["10.1200/JCO.22.00202"]}} | ||
| SRT | |a GARBECLAUSPROGNOSISO1620 | ||